1
Clinical Trials associated with Endometrial regenerative cell therapy(Medistem) / Unknown statusPhase 1/2 Allogeneic,Unrelated, Menstrual Derived, Mesenchymal Stem Cell-Like, Endometrial Cells; Administered Intramuscular
This is a 15 patient clinical trial assessing the safety and feasibility of using Endometrial Regenerative Cells (ERC) in patients with critical limb ischemia (CLI) that are not eligible for surgical or catheter-based interventions. Three doses of ERC will be examined. The hypothesis is that ERC administration will be well-tolerated and possibly induce a therapeutic benefit.
100 Clinical Results associated with Endometrial regenerative cell therapy(Medistem)
100 Translational Medicine associated with Endometrial regenerative cell therapy(Medistem)
100 Patents (Medical) associated with Endometrial regenerative cell therapy(Medistem)
100 Deals associated with Endometrial regenerative cell therapy(Medistem)